Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 34Lung Neoplasms 23Carcinoma, Non-Small-Cell Lung 18Neoplasms 15Uterine Cervical Neoplasms 9Esophageal Neoplasms 9Brain Neoplasms 8Squamous Cell Carcinoma of Head and Neck 7Solid Tumor 7Rectal Neoplasms 7Lymphoma 7Glioblastoma 7Carcinoma, Hepatocellular 7Prostatic Neoplasms 6Pancreatic Neoplasms 6Neoplasm Metastasis 6Multiple Myeloma 6Melanoma 6Hodgkin Disease 6Colorectal Neoplasms 6Colonic Neoplasms 6Carcinoma, Renal Cell 6Breast Neoplasms, Male 6Stomach Neoplasms 5Sarcoma 5Neuroendocrine Tumors 5Lymphoma, Large B-Cell, Diffuse 5Carcinoma, Transitional Cell 5Thyroid Neoplasms 4Ovarian Neoplasms 4

Interventions

Paclitaxel 7Doxorubicin 5pembrolizumab 4pazopanib 4Gemcitabine 4Bevacizumab 4durvalumab 3Radiotherapy 3Propranolol 3Docetaxel 3regorafenib 2cemiplimab 2Surveys and Questionnaires 2Sunitinib 2Standard of Care 2Nivolumab 2Ifosfamide 23-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 2zanidatamab 1veliparib 1tucatinib 1trilaciclib 1tremelimumab 1trebananib 1trastuzumab duocarmazine 1talimogene laherparepvec 1talazoparib 1spartalizumab 1sintilimab 1selinexor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Hemangiosarcoma × Fluorodeoxyglucose F18 × Clear all
NCT01462630 2022-08-19

Pazopanib Hydrochloride in Treating Patients With Advanced Angiosarcoma

Fox Chase Cancer Center

Phase 2 Completed
29 enrolled 10 charts
Sarcoma

Hemangiosarcoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡